GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BioMerieux SA (LTS:0RUG) » Definitions » Inventories, Raw Materials & Components

BioMerieux (LTS:0RUG) Inventories, Raw Materials & Components : €397 Mil (As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is BioMerieux Inventories, Raw Materials & Components?

BioMerieux's inventories, raw materials & components for the quarter that ended in Dec. 2024 was €397 Mil.

BioMerieux's quarterly raw materials increased from Dec. 2023 (€365 Mil) to Jun. 2024 (€378 Mil) and increased from Jun. 2024 (€378 Mil) to Dec. 2024 (€397 Mil).

BioMerieux's annual raw materials increased from Dec. 2022 (€306 Mil) to Dec. 2023 (€365 Mil) and increased from Dec. 2023 (€365 Mil) to Dec. 2024 (€397 Mil).


BioMerieux Inventories, Raw Materials & Components Historical Data

The historical data trend for BioMerieux's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioMerieux Inventories, Raw Materials & Components Chart

BioMerieux Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 201.10 244.90 306.10 364.60 396.90

BioMerieux Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 306.10 337.50 364.60 378.20 396.90

BioMerieux Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


BioMerieux Business Description

Industry
Traded in Other Exchanges
Address
Marcy l’Etoile, Lyon, FRA, 69280
BioMérieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (34% of 2023 sales), microbiology (39%), immunoassays (10%), and industrial applications (about 17%). The Amercas account for the largest portion of the firm's revenue (45%), followed by Europe, the Middle East, and Africa (31%), and Asia-Pacific (16%). BioMérieux is headquartered in Marcy-l'Etoile, France.

BioMerieux Headlines

No Headlines